Diagnostics: Page 17
-
Permission granted by Apple
Apple prevails in AliveCor patent dispute ahead of potential Watch import ban
Patent board ruled that all 30 claims are unpatentable because they are obvious in view of other patents.
By Nick Paul Taylor • Dec. 8, 2022 -
Phynart Studio/Getty via Getty Images
AI detects prediabetes in CGM data, opening up new use for device: study
By correctly identifying many patients with prediabetes or Type 2 diabetes, researchers say CGMs can be used to prevent the disease.
By Nick Paul Taylor • Dec. 6, 2022 -
Johnny Greig via Getty Images
The 10 biggest medtech stories of 2022
MedTech Dive reporting this year has explored how companies maintained momentum even amid supply shortages and rising inflation rates.
By MedTech Dive staff • Dec. 3, 2022 -
Drew Angerer via Getty Images
Google Health licenses breast cancer detection AI to iCAD
Applying Google’s AI to breast-cancer screening algorithms may alleviate a shortage of trained physicians and enable faster tumor treatment.
By Nick Paul Taylor • Nov. 29, 2022 -
Joe Raedle via Getty Images
Monkeypox to be renamed by WHO; ‘mpox’ will phase in over next year
The name change comes amid an outpouring of “racist and stigmatizing” language, the organization said.
By Peter Green • Nov. 28, 2022 -
Wavebreakmedia via Getty Images
Masimo’s pulse oximeter has no significant racial bias, study finds
The company said the result reflects its use of four additional signal processing engines that cut the impact of factors including skin pigmentation.
By Nick Paul Taylor • Nov. 28, 2022 -
Mario Tama via Getty Images
‘Tripledemic’ concerns spur FDA to issue emergency authorization for flu-COVID-19 combination test
Experts have warned “a viral hurricane is making landfall” as cases of RSV, influenza and COVID-19 rise simultaneously.
By Nick Paul Taylor • Nov. 23, 2022 -
sorbetto via Getty Images
AI-powered blood test detects liver cancer, opening opportunity to improve screening
Researchers claim the blood test can double the number of liver cancer cases detected and increase early cancer detection.
By Nick Paul Taylor • Nov. 22, 2022 -
Adeline Kon/Healthcare Dive/MedTech Dive
Q3 Earnings Wrap: Bumpy time for medtech with inflation, FX, supply woes
Macroeconomic pressures were a persistent theme for the industry, with workforce reductions a part of the fallout for some companies.
By Susan Kelly • Nov. 21, 2022 -
Apple Watch app for monitoring Parkinson’s symptoms earns FDA clearance
The technology has been validated in a clinical trial, positioning h2o to create an app that enables real-time sharing of Parkinson’s symptom data.
By Nick Paul Taylor • Nov. 21, 2022 -
NNehring via Getty Images
How wearable devices with skin-like stretchability may pave way for better health tracking
An AI-enabled prototype based on the stretchable technology was more than 95% effective at correctly identifying electrocardiogram signals.
By Nick Paul Taylor • Nov. 21, 2022 -
Courtesy of AEYE Health
AEYE Health wins FDA clearance for AI-powered eye test to expand diabetic screening
Approval is a first step to letting primary care physicians use a hand-held camera backed by AI to diagnose potential diabetic-related sight issues.
By Nick Paul Taylor • Nov. 18, 2022 -
Dmitry Belyaev via Getty Images
Exact Sciences founders raise $56M for new liquid biopsy venture
The new firm, called Haystack Oncology, is looking to make a test that can detect residual cancer.
By Elise Reuter • Nov. 17, 2022 -
iStock via Getty Images
Roche gets EUA for high-throughput monkeypox test
The test targets two regions of the monkeypox genome, which were picked as they are less prone to mutations than other parts of the virus.
By Nick Paul Taylor • Nov. 17, 2022 -
Scott Olson via Getty Images
How Labcorp, Abbott, BD, Siemens plan to expand home testing market
As demand wanes for COVID-19 testing, businesses see an opportunity in direct-to-consumer diagnostics.
By Elise Reuter • Nov. 16, 2022 -
Courtesy of Illumina
Illumina cuts workforce by 5% amid supply chain woes, sales slowdown
The layoffs come as the firm wrestles with flat growth and a possible forced divestiture of its GRAIL cancer-detection unit.
By Nick Paul Taylor • Nov. 15, 2022 -
Christian Petersen/Getty Images via Getty Images
Mayo Clinic creates product to test AI models for bias and inaccuracy
The proliferation of AI models has led to concerns about whether they work as intended.
By Nick Paul Taylor • Nov. 14, 2022 -
Wavebreakmedia via Getty Images
Green light shows promise in addressing oximetry racial bias: study
Researchers created a noninvasive device that performed comparably to Abbott’s invasive i-STAT in a small clinical trial.
By Nick Paul Taylor • Nov. 14, 2022 -
Courtesy of GE Healthcare
Q&AFriday Q&A: GE HealthCare’s Shetty on building accurate AI tools
The executive, who leads the company’s effort to create an integrated suite of AI tools for hospitals, warns against overloading clinicians with unconnected information.
By Elise Reuter • Nov. 11, 2022 -
Courtesy of Roche
Roche starts OTC sales of COVID-19 test in first push into US market
CVS, Amazon and the Optum Store are stocking the product, rebranded Pilot.
By Nick Paul Taylor • Nov. 11, 2022 -
Phynart Studio/Getty via Getty Images
Medtech execs ‘rethink’ long-term strategies as care settings shift: Accenture report
The move from hospitals to ambulatory and at-home care is only just beginning, the survey found.
By Nick Paul Taylor • Nov. 10, 2022 -
Courtesy of Dr. Nada Ali/University of Washington
Affordable alternative: Smartphone-based hearing test for infants targets developing countries
The off-the-shelf alternative has a material cost of $10, giving children in impoverished regions easier access to vital monitoring and diagnosis.
By Nick Paul Taylor • Nov. 9, 2022 -
Retrieved from Siemsens Website on July 01, 2022
Siemens Healthineers beats sales forecasts on imaging demand as diagnostic pressures prompt restructuring
Siemens Healthineers is revamping its diagnostics unit after concluding that “external headwinds [are] outweighing operational improvements.”
By Nick Paul Taylor • Nov. 9, 2022 -
James Mutter via Getty Images
Quest broadens access to COVID-19 multiplex tests as flu cases rise
The new procedure is meant to encourage the use of tests that detect multiple respiratory viruses as the U.S. prepares for a challenging flu season.
By Elise Reuter • Nov. 3, 2022 -
Courtesy of Hologic
Hologic quarterly sales beat forecast even as demand for COVID tests wanes
The company expects its surgical and breast health businesses to rebound in fiscal 2023.
By Nick Paul Taylor • Nov. 1, 2022
Previous
